Astrazeneca Pharma India Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 13, 2011 has recommended a dividend of Rs 10/- per Equity Share of a face value of Rs 2/- each for the Financial Year (15 months period) ended March 31, 2011, subject to the approval of the shareholders at the ensuing Annual General Meeting.Source : BSE
